Alternate-form reliability of the montreal cognitive assessment screening test in a clinical setting

Dementia and Geriatric Cognitive Disorders

Volumn 33, Issue 6, 2012, Pages 379-384

  Costa, Ana S ^a   Fimm, Bruno ^a   Friesen, Paul ^a   Soundjock, Herve ^a   Rottschy, Claudia ^a,b,c,d   Gross, Theresa ^a   Eitner, Frank ^a   Reich, Arno ^a   Schulz, Jörg B ^a,b   Nasreddine, Ziad S ^e   Reetz, Kathrin ^a,b,c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b JARA   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Alternate Form; Alzheimer's disease; MCI; Reliability; Screening test

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EDUCATIONAL STATUS; FEMALE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT SCREENING TEST; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VALIDITY;

AGE FACTORS; AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 84863730519     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000340006     Document Type: Article

References (39)

1. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699. (Pubitemid 41623495)
2. Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM: The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord 2010;25:401-404.
3. Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ: The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010;75: 1717-1725.
4. Kasten M, Bruggemann N, Schmidt A, Klein C: Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2010;75:478, author reply 478-479.
5. Godefroy O, Fickl A, Roussel M, Auribault C, Bugnicourt JM, Lamy C, Canaple S, Petitnicolas G: Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke 2011;42:1712-1716.
6. McLennan SN, Mathias JL, Brennan LC, Stewart S: Validity of the Montreal Cognitive Assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol 2011;24:33-38.
7. Appels B, Scherder E: The diagnostic accuracy of dementia-screening instruments with an administration time of 10 to 45 minutes for use in secondary care: a systematic review. Am J Alzheimers Dis Other Demen 2010; 25:301-316.
8. Coen RF, Cahill R, Lawlor BA: Things to watch out for when using the Montreal Cognitive Assessment (MoCA). Int J Geriatr Psychiatry 2011;26:107-108.
9. Luis CA, Keegan AP, Mullan M: Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry 2009;24:197-201.
10. Rossetti HC, Lacritz LH, Cullum CM, Weiner MF: Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 2011;77: 1272-1275.
11. Ismail Z, Rajji TK, Shulman KI: Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 2010;25:111-120.
12. Damian AM, Jacobson SA, Hentz JG, Belden CM, Shill HA, Sabbagh MN, Caviness JN, Adler CH: The Montreal Cognitive Assessment and the Mini-Mental State Examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord 2011; 31:126-131.
13. Bernstein IH, Lacritz L, Barlow CE, Weiner MF, DeFina LF: Psychometric evaluation of the Montreal Cognitive Assessment (MoCA) in three diverse samples. Clin Neuropsychol 2011;25:119-126.
14. Deutsche Gesellschaft fü r Psychiatrie, Psychotherapie, und Nervenheilkunde und Deutsche Gesellschaft fü r NeurologieNeurologie: Diagnose-und Behandlungsleitlinie Demenz. Berlin, Springer, 2010.
15. Aebi C: Validierung der Neuropsychologischen Testbatterie CERAD-NP: Eine Multicenter Studie (Validation of the CERAD Neuropsychological Assessment Battery: A Multicenter Study). Basel, Universität Basel, 2002.
16. Härting C, Markowitsch H, Neufeld H, Calabrese P, Deisinger K: Wechsler Gedächtnis Test -Revidierte Fassung. Bern, Hans Huber, 2000.
17. von Aste M, Neubauer A, Horn R: Wechsler Intelligenztest für Erwachsene (WIE). Deutschsprachige Bearbeitung und Adaptation des WAIS-III von David Wechsler. Frankfurt, Harcourt Test Services, 2006.
18. Warrington E, James M: Testbatterie für Visuelle Objekt-und Raumwahrnehmung (VOSP). Frankfurt, Harcourt Test Services, 1992.
19. Bäumler G: Farbe-Wort-Interferenztest. Göttingen, Hogrefe, 1985.
20. Petersen R: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256: 183-194. (Pubitemid 39222988)
21. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P: Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010;9:1118-1127.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944. (Pubitemid 14076461)
23. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-746. (Pubitemid 47058377)
24. Gauggel S, Birkner B: Validity and reliability of the German version of the geriatric depression scale (in German). Z Klin Psychol Psychother 1999;28:18-27. (Pubitemid 29075534)
25. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB, Leirer VO: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983;17:37-49. (Pubitemid 13123113)
26. Monsch AU, Foldi NS, Ermini-Fünfschilling DE, Berres M, Taylor KI, Seifritz E, Stähelin HB, Spiegel R: Improving the diagnostic accuracy of the Mini-Mental State Examination. Acta Neurol Scand 2009;92:145-150.
27. Aschenbrenner S, Tucha O, Lange KW: Regensburger Wortflüssigkeits- Test (Regensburg Word Fluency Test). Göttingen, Hogrefe, 2000.
28. Schmidt KS, Mattis PJ, Adams J, Nestor P: Alternate-form reliability of the Dementia Rating Scale-2. Arch Clin Neuropsychol 2005; 20:435-441. (Pubitemid 40719548)
29. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L: Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-164.
30. Kessler J, Markowitsch HJ, Denzler P: Mini-Mental-Status-Test (MMST) (German adaptation). Göttingen, Beltz Test GmbH, 2000.
31. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1988.
32. Heilbronner RL, Sweet JJ, Attix DK, Krull KR, Henry GK, Hart RP: Official position of the American Academy of Clinical Neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contexts. Clin Neuropsychol 2010;24: 1267-1278.
33. Groth-Marnat G: Handbook of psychological assessment. Hoboken, Wiley, 2009.
34. Benedict RH, Zgaljardic DJ: Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 1998;20:339-352. (Pubitemid 28539554)
35. Beglinger LJ, Gaydos B, Tangphao-Daniels O, Duff K, Kareken DA, Crawford J, Fastenau PS, Siemers ER: Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol 2005;20: 517-529. (Pubitemid 40719554)
36. Freitas S, Simões MR, Alves L, Santana I: Montreal Cognitive Assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 2011, DOI: 10.1097/WAD.013e3182420bfe
37. Wong A, Xiong YY, Kwan PW, Chan AY, Lam WW, Wang K, Chu WC, Nyenhuis DL, Nasreddine Z, Wong LK, Mok VC: The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord 2009;28:81-87.
38. Waldron-Perrine B, Axelrod BN: Determining an appropriate cutting score for indication of impairment on the Montreal Cognitive Assessment. Int J Geriatr Psychiatry 2012, DOI: 10.1002/gps.3768.
39. Freitas S, Simões MR, Alves L, Santana I: Montreal Cognitive Assessment (MoCA): normative study for the Portuguese population. J Clin Exp Neuropsychol 2011;33: 989-996.